Nl8902 !new! -

The identification code refers to a significant clinical trial officially registered in the Netherlands Trial Register. Known as the RALLY study , it represents a pioneering effort in oncology, specifically targeting patients with hepatocellular carcinoma (HCC) who were previously considered ineligible for surgery. What is the RALLY Study (NL8902)?

The RALLY study also acts as a "test of time." Because it takes several months for the liver to grow, physicians can monitor if new metastases appear elsewhere. If the cancer spreads during this window, it prevents patients from undergoing a high-risk, major surgery that would no longer be curative. Clinical Impact nl8902